• Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘Onyx Pharmaceuticals Inc (ONXX)’

FARALLON CAPITAL

Farallon Capital Management Adds Sycamore Networks Inc. (SCMR) To Its Equity Portfolio

Farallon Capital Management, in latest filing, disclosed that it initiated a position in Sycamore Networks, Inc. (OTCMKTS:SCMR), reporting ownership of...

Keep Reading →

January 14 - Hedge Funds, News - Comments

Exelixis, Inc. (NASDAQ:EXEL)

An Excellent Investment in the Biotech Space?

According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected...

Keep Reading →

September 23 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): Revelations From This Blazing Biotech

Blazing. Sizzling. On fire. They all describe Celgene Corporation (NASDAQ:CELG) pretty well these days. With all of the heat generated by this biotech...

Keep Reading →

September 16 - News - Comments

Seattle Genetics, Inc. (NASDAQ:SGEN)

Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?

At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment...

Keep Reading →

September 10 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): When Will the Good News End for This Biotech?

They say that bad news comes in threes. I’m not sure if there’s a similar saying for good news, but for Celgene Corporation (NASDAQ:CELG)...

Keep Reading →

September 5 - News - Comments

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

Astex Pharmaceuticals, Inc. (ASTX) Becomes the Latest Biotech Domino to Fall

Another domino has fallen in the world of biotech. Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) is being scooped up by Tokyo-based Otsuka Pharmaceuticals...

Keep Reading →

September 5 - News - Comments

VIVUS, Inc. (NASDAQ:VVUS)

Pharma News Highlights: VIVUS, Inc. (VVUS) New CEO, Arena Pharmaceuticals, Inc. (ARNA)’s Rating, Amgen, Inc. (AMGN)’s Acquisition

Editor’s Note: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen, Inc. (NASDAQ:AMGN), Onyx Pharmaceuticals, Inc. (...

Keep Reading →

September 5 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Astex Pharmaceuticals, Inc. (ASTX), Pharmacyclics, Inc. (PCYC): This Week in Biotech

With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into...

Keep Reading →

September 1 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Monday’s Best Stocks

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case...

Keep Reading →

August 27 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Amgen, Inc. (AMGN), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Onyx Pharmaceuticals, Inc. (ONXX): This Biotech Envisions Green

After a second offer, Amgen, Inc. (NASDAQ:AMGN) and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX), a maker of drugs to fight cancer among other diseases,...

Keep Reading →

August 27 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

The Amgen, Inc. (AMGN)-Onyx Pharmaceuticals, Inc. (ONXX) Deal Should Make All Biotech Investors Happy

As I’m sure you’ve probably heard by now, Amgen, Inc. (NASDAQ:AMGN) agreed to purchase Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) for $125...

Keep Reading →

August 26 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX), NASDAQ OMX Group, Inc. (NDAQ): Deals, Not Data, Drive Dow Today

Although we don’t believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes — just in case...

Keep Reading →

August 26 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN) and Onyx Pharmaceuticals, Inc. (ONXX): Half a Billion Dollars’ Worth of Drama

A finale has at last arrived for the biotech drama of summer 2013. Amgen, Inc. (NASDAQ:AMGN) announced yesterday that it will buy Onyx Pharmaceuticals...

Keep Reading →

August 26 - News - Comments

Vertex Pharmaceuticals Incorporated

What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)

Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a buy? In the 21st century investor’s toolkit, there are tons of metrics market participants can...

Keep Reading →

August 26 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

What Is Amgen, Inc. (AMGN) Getting For Its Money?

Although we don’t believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes — just in case...

Keep Reading →

August 26 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use...

Keep Reading →

August 26 - News - Comments

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)

Should you be crazy about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)? In the financial world, there are dozens of gauges shareholders can use to analyze...

Keep Reading →

August 26 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Amgen, Inc. (AMGN), AstraZeneca plc (ADR) (AZN): What’s the Big Deal About Onyx Pharmaceuticals, Inc. (ONXX) Anyway?

At the end of June, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) announced that it had rejected an offer from Amgen, Inc. (NASDAQ:AMGN) that valued the...

Keep Reading →

August 24 - News - Comments

Illumina, Inc. (NASDAQ:ILMN)

Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?

If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times. Although there are more...

Keep Reading →

August 23 - News - Comments

Seattle Genetics, Inc. (NASDAQ:SGEN)

Medivation Inc (MDVN), Seattle Genetics, Inc. (SGEN) – Biotech Buyouts: Who’s Next?

There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (...

Keep Reading →

August 23 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): Celgene Corporation (CELG)’s Multiple Myeloma Powerhouse

Earlier this month, biotech powerhouse Celgene Corporation (NASDAQ:CELG) announced that the European Commission approved the combinational therapy of...

Keep Reading →

August 22 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN), Alexion Pharmaceuticals, Inc. (ALXN): Biotech’s Falling Fortunes Stymie Osiris Therapeutics, Inc. (OSIR)’s Huge Week

Biotech’s the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling...

Keep Reading →

August 19 - News - Comments

Novartis AG (ADR) (NYSE:NVS)

Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)’s Buyout Radar

The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is really beginning to heat up, and it’s offering investors...

Keep Reading →

August 16 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Compugen Ltd. (USA) (CGEN): This Week in Biotech

With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...

Keep Reading →

August 12 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): A Closer Look at the Battle Over Cancer Treatments

Over the past year, the battle over cancer treatments has heated up considerably. Big pharma companies such as Amgen, Inc. (NASDAQ:AMGN), Pfizer Inc. (...

Keep Reading →

August 7 - News - Comments

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): Will This Orphan Drug Maker Find a New Home?

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), already quite expensive, spiked higher since takeover rumors surfaced in early July. But can a deal give...

Keep Reading →

August 6 - News - Comments

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): This Orphan Drug Company Only Appears Expensive

In the last couple of months, we saw two big offers being made – and rejected – in the biotech sector. Both times, the companies that rejected...

Keep Reading →

August 5 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Has Multiple Myeloma Met its Match?

Multiple myeloma is a cancer of plasma cells, a type of white blood cell present in bone marrow. This cancer can lead to abnormally high calcium levels...

Keep Reading →

July 26 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Will This Biotech Bidding War Lead You to Larger Gains?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout. Reportedly, four...

Keep Reading →

July 24 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Why Getting Rich Quick Doesn’t (Always) Pay

We have a bona fide biotech soap opera going on these days. Spurned love. Possible romance. Disgruntled suitor. And, of course, the unknown villain. In...

Keep Reading →

July 24 - News - Comments

Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ), Onyx Pharmaceuticals, Inc. (ONXX), Seattle Genetics, Inc. (SGEN): Betting on Blockbusters

Global biotechnology industry revenue is expected to reach $262 billion this year showing growth of around 12.7% year over year. This industry has witnessed...

Keep Reading →

July 22 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN)’s Acquisition Ambition Leads Biotechs’ Rise

Biotech’s the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling...

Keep Reading →

July 22 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Expanding Labels to Expand Margins

In an industry where buyouts are commonplace and small-cap biotechs burn through cash rapidly, optimizing operating cash flow can be essential to a company...

Keep Reading →

July 19 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)

The “people familiar with the matter” are out in full force spouting off about who’s bidding for Onyx Pharmaceuticals, Inc. (NASDAQ...

Keep Reading →

July 19 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Can This Biotech Go Even Higher?

Celgene Corporation (NASDAQ:CELG) has emerged as the leading treatment provider for blood cancer. The company value has almost doubled in the last year...

Keep Reading →

July 19 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): A Fundamentally Strong Biotech Stock

Celgene Corporation (NASDAQ:CELG) surged 7% on Thursday, July 11, 2013 on news that the Phase III trials of Revlimid /dexamethasone combination showed...

Keep Reading →

July 18 - News - Comments

Pfizer Inc. (NYSE:PFE)

Is Pfizer Inc. (PFE) Destined for Greatness?

Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable...

Keep Reading →

July 18 - News - Comments

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Onyx Pharmaceuticals, Inc. (ONXX), Alexion Pharmaceuticals, Inc. (ALXN): 3 Biotechs That Could Be Bought Out This Year

Buyout! The word gets biotech investors’ blood flowing and their hearts racing. Mere rumors that a biotech stock could get bought out can send shares...

Keep Reading →

July 17 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Revlimid Results Rev Up Celgene Corporation (CELG)

Good news seems to find its way to Celgene Corporation (NASDAQ:CELG)‘s door frequently these days. The company announced positive results today...

Keep Reading →

July 11 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Who Could Buy Onyx Pharmaceuticals, Inc. (ONXX) and at What Price?

Recently Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) rejected a $10 billion takeover offer from Amgen, Inc. (NASDAQ:AMGN). However, after that it hired an...

Keep Reading →

July 10 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Who Is the Best Suitor for Onyx Pharmaceuticals, Inc. (ONXX)?

Cancer-drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) recently rejected an $8.7 billion unsolicited acquisition offer from Amgen, Inc. (NASDAQ:...

Keep Reading →

July 10 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Pharmacyclics, Inc. (PCYC): Will This Biotech Acquisition Buzz Lead to More Buyouts?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is trading higher after rejecting a takeover bid. As other stocks in its sector also trade higher in sympathy...

Keep Reading →

July 9 - News - Comments

Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN) Stirs the Pot in the Cancer-Related Sector

Several companies are fighting to be the first to release a treatment or cure for cancer that is a game-changer, and this battle has created a field where...

Keep Reading →

July 8 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Achillion Pharmaceuticals, Inc. (ACHN): This Week in Biotech

With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...

Keep Reading →

July 8 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Celldex Therapeutics, Inc. (CLDX): Three Humongous Health-Care Stocks This Week

While many American skies were lit up with fireworks this week, the stock market also saw its share of pops, sizzles, and bangs. Here are three health...

Keep Reading →

July 8 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is having a garage sale, but it doesn’t appear that Amgen, Inc. (NASDAQ:AMGN) has been invited. The promising...

Keep Reading →

July 5 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Is This Biopharmaceutical Stock Still a Buy?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) has recently experienced a significant jump of nearly 51.3% in only one trading day from $86.82 per share to $...

Keep Reading →

July 5 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Is This A Good Acquisition For All?

For the second day in a row, the hot topic in the market is the bidding war for Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX). After rejecting Amgen, Inc. (...

Keep Reading →

July 3 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Avoid This Biotech Investment, For Now

Mergers and acquisitions have always been a big part of the biotechnology industry, and the patent cliff has further increased M&A activity. We are...

Keep Reading →

July 3 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX) Bidding Wars: Who Would Be the Best Suitor?

A lot of activity is happening in the biotech industry which would change the dynamics of the large cancer related drug makers. Recently, Amgen, Inc. (...

Keep Reading →

July 3 - News - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$202,411,166,000

David Einhorn

David Einhorn

Greenlight Capital

$922,283,000

George Soros

George Soros

Soros Fund Management

$4,481,502,000

Jim Simons

Jim Simons

Renaissance Technologies

$115,840,763,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$873,897,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$19,724,532,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$15,331,618,000

John Paulson

John Paulson

Paulson & Co

$3,129,243,000

David Tepper

David Tepper

Appaloosa Management LP

$5,758,450,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$2,017,669,000

Insider Monkey Small Cap Strategy
Most Read Posts
Dump Your Hedge Funds and Buy This Stock
World’s Most Expensive Desserts
The 10 Best Selling Products Online
The 10 Best Selling Items on Etsy
The 12 Most Profitable Small Businesses
The 10 Best-Selling Video Games of All Time
Lists

15 Largest Cruise Companies in the World

5 Largest Cruise Companies in the World

Top 15 Emerging Companies In India

Top 5 Emerging Companies In India

15 Biggest Renewable Energy Companies and Stocks

5 Biggest Renewable Energy Companies and Stocks

15 Fastest Growing Biotech Companies in the US

5 Fastest Growing Biotech Companies in the US

15 Most Valuable Alcohol Companies

5 Most Valuable Alcohol Companies

15 Most Valuable Asian Companies

5 Most Valuable Asian Companies

20 Most Valuable Companies In The World in February 2021

Top 15 Pharmaceutical Companies With Highest R&D Spending

Top 5 Financial Centers/Cities of The World

Top 15 Financial Centers/Cities of The World

15 Most Valuable Cloud Computing Companies

5 Most Valuable Cloud Computing Companies

15 Fastest-Growing Fintech Companies

5 Fastest-Growing Fintech Companies

15 Biggest Companies That Accept Bitcoin

15 Youngest Tech Billionaires

Top 15 Serial Entrepreneurs In The World

15 Most Powerful and Influential Companies

12 Most Influential Entrepreneurs in America

15 Richest People in Central and South America

10 Emerging Energy Technologies You Can Invest In Today

15 Richest People In Canada

15 Biggest Water Companies in the World

15 Biggest Acquisitions Of All Time

15 Fastest Growing Dividend Stocks

15 Biggest VC Companies in the World

5 Biggest VC Companies in the World

15 Biggest Trucking Companies in the World

15 Biggest Tech Hardware Companies in the World

5 Biggest Tech Hardware Companies in the World

15 Biggest Wine Companies in the World

25 Highest Earning Billionaires in 2020

15 Fastest-Growing Software Companies

15 Biggest Yogurt Companies in the World

Easily Digestible and Delicious Recipes For Elderly

5 Fastest-Growing Software Companies

5 Fastest-Growing Engineering Fields

15 Biggest Lithium Mining Companies in the World

15 Fastest-Growing Engineering Fields

15 Biggest Companies That Went Bankrupt

Top 10 Most Deadliest and Dangerous Snakes In the World

20 Most Deadliest and Dangerous Snakes In the World

10 Easiest Occupational Therapy Schools To Get Into

Top 5 Easiest Occupational Therapy Schools To Get Into

Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse
Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use CCPA - Do Not Sell My Information
All text and design is copyright ©2021 Koala Guide LLC. All rights reserved.